NutropinAq (somatropin): Reviews and patient testimonials

NutropinAq 10mg/2mL

Paediatric population

- Long-term treatment of children with growth failure due to inadequate endogenous growth hormone secretion.

- Long-term treatment of girls from 2 years old with growth failure associated with Turner syndrome.

- Treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation.

Adult population

- Replacement of endogenous growth hormone in adults with growth hormone deficiency of either childhood or adult-onset etiology. Growth hormone deficiency should be confirmed appropriately prior to treatment.

In adults with growth hormone deficiency the diagnosis should be established depending on the etiology:

Adult-onset: The patient must have growth hormone deficiency as a result of hypothalamic or pituitary disease, and at least one other hormone deficiency diagnosed (except for prolactin). Test for growth hormone deficiency should not be performed until adequate replacement therapy for other hormone deficiencies have been instituted.

Childhood-onset: Patients who have had growth hormone deficiency as a child should be retested to confirm growth hormone deficiency in adulthood before replacement therapy with NutropinAq is started.

Molecule: somatropin